Restrictions on fungicide Iblon (isoflucypram), that limited its use to one application every two years, have been lifted.
The change follows the successful submission and evaluation of data submitted by Bayer, and means growers can utilise Vimoy (Iblon)’s broad-spectrum efficacy now.
For other Iblon-containing products such as Jessico Fusion (Iblon+ Inatreq (fenpicoxamid)), Plaxium (Iblon+ prothioconazole+ fluopyram), Caley, Ipresso, Resilis, Milteo, Scorpio or Vivalis (all Iblon+ prothioconazole), the previous restriction limiting use to one application every two years will be lifted for the 2026 season, meaning these products can be applied to approved crops grown in the same field in successive years.
The decision was announced at the same time that CRD also granted a label extension allowing for Vimoy to be used on barley, thereby expanding options for the 2026 cropping season.
Nils Bauer, managing director of Bayer Crop Science, says the news is an excellent opportunity to unleash the full potential of Iblon. “This is very good news for GB growers, many of whom have come to appreciate the broad-spectrum performance of Iblon, and its ability to improve yield through extended crop greening even where disease pressure is low, as it’ll extend crop protection to successive crops grown in the same field.”
